Over 132 Years Ago, the Inaugural Immunotherapy Treated Its First Head and Neck Cancer Patient

Documents similaires

• Ethics in Practice: Immunotherapy at End of Life in Head and Neck Cancer
  par: Sholem Hack, et autres
  Publié: (2026)
• Decisional Conflict in Palliative Head and Neck Cancer Patients
  par: Boyd N. van den Besselaar, et autres
  Publié: (2026)
• Effect of Sarcopenia on Swallowing in Patients With Head and Neck Cancer
  par: Angela A. Colback, et autres
  Publié: (2024)
• Comparison of Swallowing Measures to Patient‐Reported Dysphagia Symptoms in Head and Neck Cancer Patients
  par: Timothy Delaney, et autres
  Publié: (2024)
• Prevalence of Pain and Associated Clinical Characteristics in 10‐Year Survivors of Head and Neck Cancer
  par: M. Bryant Howren, et autres
  Publié: (2024)